2016

London, UK, 02 August 2016 BTG plc (LSE: BTG), a global specialist healthcare company, today announced that it has obtained European Conformity (CE) Mark from the Notified Body British Standards...

London, UK, 27 July 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces the appointment of Graham Hetherington as a non-executive director of the Board and Chair of the...

London, UK, 14 July 2016 BTG plc (LSE: BTG), the specialist healthcare company provides the following business update ahead of its Annual General Meeting, which will be held today at 10.30 am at...

West Conshohocken, PA, US, 06 July 2016 BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation...

London, UK, 15 June 2016 BTG plc (LSE: BTG), the specialist healthcare company, is pleased to announce that it has completed the acquisition of Galil Medical, a leading provider of cryoablation...

London, UK, 09 June 2016 BTG, a global leader in interventional oncology, announced today that it has joined the Global Liver Institute’s Partnership Network as a founding member. The Global...

02 June 2016 BTG plc (LSE: BTG), a global specialist healthcare company, today announced plans to initiate the TheraSphere® Advanced Dosimetry Retrospective Global Study Evaluation in...

WASHINGTON D.C, 26 May 2016 New study highlights potential cost savings when using yttrium-90 glass microspheres for treatment of hepatocellular carcinoma TARE (transarterial radio-embolization)...

London, UK, 17 May 2016 BTG plc (LSE: BTG), the specialist healthcare company, today announces its final results for the year ended 31 March 2016. Click here to download the results release PDF

London, UK, 06 May 2016 Builds on BTG’s leadership in Interventional Oncology, expanding franchise into attractive and complementary ablation market Galil Medical is a leader in cryoablation of...